Florian Rumpf
Harvard University
6 Papers
Florian Rumpf is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Germline. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons
Md. Tarikul Islam,Florian Rumpf,Yusuke Tsuno,Shota Kodani,Takeshi Sakurai,Ayako Matsui,Takashi Maejima,Michihiro Mieda +7 more
TL;DR: In this article , the authors reported the involvement of Arginine vasopressin neurons in arousal promotion in the paraventricular nucleus of the hypothalamus (PVHAVP) and showed that PVHAVP neurons promote wakefulness via orexin/hypocretin (LHOrx) neurons.
19
Mp43-10 impact of family history and germline genetic risk variants on long-term outcomes of active surveillance-eligible prostate cancer
Florian Rumpf,Anna Plym,J. Bailey Vaselkiv,Mark A. Preston,Adam S. Kibel,Lorelei A. Mucci,Keyan Salari +6 more
TL;DR: Rumpf et al. as discussed by the authors evaluated the impact of a positive family history and germline risk SNPs on outcomes on active surveillance eligible patients and found that men with a positive history had an 83% higher risk of PCa-specific death.
Conditional survival in men on active surveillance for prostate cancer
Hersh H. Bendre,Florian Rumpf,Andrew Gusev,Matthew W. Wszolek,Douglas Dahl,Michael L. Blute,A. Feldman,K. Salari +7 more
TL;DR: This study examines conditional survival in men with prostate cancer on active surveillance, finding that the risk of disease progression decreases over time, with patients who remain on surveillance longer experiencing improved survival outcomes.
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
Florian Rumpf,Anna Plym,J. Bailey Vaselkiv,Kathryn L. Penney,Mark A. Preston,Adam S. Kibel,Lorelei A. Mucci,K. Salari +7 more
TL;DR: Family history of prostate, breast, or pancreatic cancer and/or a 19q13 germline risk allele are associated with an elevated risk of prostate cancer‒specific death among favorable-risk patients and have implications for how family history and germline genetic risk SNPs should be factored into clinical decision-making around favorable-risk prostate cancer.
Serum Biomarkers for Risk Stratification of Prostate Cancer Patients on Active Surveillance by Untargeted 1H MRS Metabolomics
Leo Cheng,Florian Rumpf,Matteo Sanchez-Dahl Gonzalez,Adam Feldman +3 more